Aggressive surgical effort and improved survival in advanced-stage ovarian cancer
GD Aletti, SC Dowdy, BS Gostout, MB Jones… - Obstetrics & …, 2006 - journals.lww.com
OBJECTIVE: Residual disease after initial surgery for ovarian cancer is the strongest prognostic
factor for survival. However, the extent of surgical resection required to achieve optimal …
factor for survival. However, the extent of surgical resection required to achieve optimal …
[HTML][HTML] A randomized trial of lymphadenectomy in patients with advanced ovarian neoplasms
…, JW Kim, F Raspagliesi, B Lampe, G Aletti… - … England Journal of …, 2019 - Mass Medical Soc
Background Systematic pelvic and paraaortic lymphadenectomy has been widely used in the
surgical treatment of patients with advanced ovarian cancer, although supporting evidence …
surgical treatment of patients with advanced ovarian cancer, although supporting evidence …
Relationship among surgical complexity, short-term morbidity, and overall survival in primary surgery for advanced ovarian cancer
GD Aletti, SC Dowdy, KC Podratz, WA Cliby - American journal of obstetrics …, 2007 - Elsevier
BACKGROUND: Advanced ovarian cancer (OC) is associated with impaired performance
status and comorbidities for many patients. These factors have an impact on the decision to …
status and comorbidities for many patients. These factors have an impact on the decision to …
Identification of patient groups at highest risk from traditional approach to ovarian cancer treatment
GD Aletti, EL Eisenhauer, A Santillan, A Axtell… - Gynecologic …, 2011 - Elsevier
OBJECTIVE: Define subgroups of patients at highest risk for major morbidity and mortality after
a traditional approach of maximal surgical efforts followed by chemotherapy for advanced …
a traditional approach of maximal surgical efforts followed by chemotherapy for advanced …
Current management strategies for ovarian cancer
GD Aletti, MM Gallenberg, WA Cliby, A Jatoi… - Mayo Clinic …, 2007 - Elsevier
Epithelial ovarian cancer originates in the layer of cells that covers the surface of the ovaries.
The disease spreads readily throughout the peritoneal cavity and to the lymphatics, often …
The disease spreads readily throughout the peritoneal cavity and to the lymphatics, often …
A new frontier for quality of care in gynecologic oncology surgery: multi-institutional assessment of short-term outcomes for ovarian cancer using a risk-adjusted model
GD Aletti, A Santillan, EL Eisenhauer, J Hu, G Aletti… - Gynecologic …, 2007 - Elsevier
OBJECTIVE: To test the feasibility and utility of a risk-adjusted, multicenter outcomes model
for ovarian cancer surgery as a tool for quality improvement. METHODS: Patient …
for ovarian cancer surgery as a tool for quality improvement. METHODS: Patient …
Ovarian cancer surgical resectability: relative impact of disease, patient status, and surgeon
GD Aletti, BS Gostout, KC Podratz, WA Cliby - Gynecologic oncology, 2006 - Elsevier
OBJECTIVES.: Currently, we are unable to predict which patients are most likely to undergo
successful debulking of ovarian cancer. We investigated the impact of clinical and surgical-…
successful debulking of ovarian cancer. We investigated the impact of clinical and surgical-…
Impact of morcellation on survival outcomes of patients with unexpected uterine leiomyosarcoma: a systematic review and meta-analysis
G Bogani, WA Cliby, GD Aletti - Gynecologic oncology, 2015 - Elsevier
Objective To review the current evidence on the effects of intra-abdominal morcellation on
survival outcomes of patients affected by unexpected uterine leiomyosarcoma (ULMS) and to …
survival outcomes of patients affected by unexpected uterine leiomyosarcoma (ULMS) and to …
Surgical treatment of diaphragm disease correlates with improved survival in optimally debulked advanced stage ovarian cancer
GD Aletti, SC Dowdy, KC Podratz, WA Cliby - Gynecologic oncology, 2006 - Elsevier
BACKGROUND.: Diaphragm involvement by ovarian cancer is often considered to be a
major obstacle to successful cytoreductive surgery. Lack of evidence of survival benefit, …
major obstacle to successful cytoreductive surgery. Lack of evidence of survival benefit, …
Integrated FDG PET/CT in patients with persistent ovarian cancer: correlation with histologic findings
S Sironi, C Messa, G Mangili, B Zangheri, G Aletti… - Radiology, 2004 - pubs.rsna.org
PURPOSE: To prospectively evaluate the accuracy of integrated positron emission tomography
(PET) and computed tomography (CT) for depiction of persistent ovarian carcinoma after …
(PET) and computed tomography (CT) for depiction of persistent ovarian carcinoma after …